Cushman & Wakefield recently released its Life Sciences —— Changing the Genetics of China's Commercial Real Estate report. The life sciences industry, as one of China's strategic emerging industries, has witnessed tremendous growth over recent years. China itself has become one of the most important life sciences markets globally. Driven by a host of factors, including:
- Organic industry growth;
- Population demographics;
- Spending power – public and private;
- National health coverage;
- Policy and reform, and;
- Research and innovation…
…China’s life sciences sector has also not gone unnoticed by investors in the sector, whether it’s government investment, corporate investment, or private individual investment.
Shaun Brodie, Head of Occupier Research, Greater China, Cushman & Wakefield said, “The life sciences industry in China will follow the global trend and continue to innovate in a variety of ways, including digital innovation in medical and pharmaceutical services and the application of artificial intelligence within the whole industry chain. Thus, the industry will continue to drive investment in commercial spaces such as laboratories, office buildings and industrial parks. With the continuous advancement of the industry in general, we are looking forward to life sciences being a catalyst that contributes to a change in the genetics of commercial real estate in China.”
When considering the life sciences industry and the related real estate market at the city level, China has a number of important markets. For the purposes of this report, we have examined four of them: the four first-tier cities of Beijing, Shanghai, Shenzhen, and Guangzhou. Ahead, it is expected that most major cities in China will achieve significant breakthroughs in the life sciences industry during “14th Five Year Plan” period.
Please click here to download the full report
